Heron Therapeutics, Inc. (HRTX)

Heron Therapeutics Revenue

In the year 2023, Heron Therapeutics had annual revenue of $127.04M with 17.99% growth. Revenue in the quarter ending December 31, 2023 was $34.23M with 14.00% year-over-year growth.

• Revenue (ttm): $127.04M
• Revenue Growth: +17.99%
• P/S Ratio: 2.90
• Revenue / Employee: $1,008,286
• Employees: 126
• Market Cap: 368.31M USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	127.04M	19.37M	17.99%
Dec 31, 2022	107.67M	21.33M	24.70%
Dec 31, 2021	86.35M	-2.29M	-2.59%
Dec 31, 2020	88.64M	-57.33M	-39.28%
Dec 31, 2019	145.97M	68.49M	88.41%
Dec 31, 2018	77.47M	46.71M	151.81%
Dec 31, 2017	30.77M	29.49M	2,305.55%
Dec 31, 2016	1.28M	-	-
Dec 31, 2015	0	-	-
Dec 31, 2014	0	-	-
Dec 31, 2013	0	-	-
Dec 31, 2012	0	-	-
Dec 31, 2011	646.00K	-655.00K	-50.35%
Dec 31, 2010	1.30M	40.00K	3.17%
Dec 31, 2009	1.26M	892.00K	241.73%
Dec 31, 2008	369.00K	-43.00K	-10.44%
Dec 31, 2007	412.00K	-	-
Dec 31, 2006	0	-	-
Dec 31, 2005	5.39M	-13.00K	-0.24%
Dec 31, 2004	5.40M	556.00K	11.47%
Dec 31, 2003	4.85M	178.00K	3.81%
Dec 31, 2002	4.67M	1.41M	43.03%
Dec 31, 2001	3.27M	-101.00K	-3.00%
Dec 31, 2000	3.37M	-1.33M	-28.33%
Dec 31, 1999	4.70M	1.62M	52.77%
Dec 31, 1998	3.07M	-14.13M	-82.13%
Dec 31, 1997	17.21M	-453.96K	-2.57%
Dec 31, 1996	17.66M	1.55M	9.64%
Dec 31, 1995	16.11M	223.75K	1.41%
Dec 31, 1994	15.88M	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.